Bladder cancer: Photodynamic diagnosis can improve surgical outcome

Nature Reviews Urology

Volumn 7, Issue 11, 2010, Pages 598-599

  O'Brien, Tim ^a   Thomas, Kay ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER;

BLADDER CANCER; BLUE LIGHT; CANCER GROWTH; CANCER RECURRENCE; CYSTOSCOPY; ENDOSCOPIC SURGERY; GERMANY; HIGH RISK PATIENT; HUMAN; PHOTODYNAMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

CYSTOSCOPY; HUMANS; LIGHT; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 78549292832     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2010.183     Document Type: Short Survey

References (6)

1. Kriegmair, M. et al. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J. Urol. 155, 105-110 (1996).
2. Geavlete, B., Jecu, M., Multescu, R., Georgescu, D. & Geavlete P. HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer\re-TURBT recurrence rates in a prospective, randomized study. Urology 76, 664-669 (2010).
3. Babjuk, M. et al. eAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur. Urol. 54, 303-314 (2008).
4. Ray, E. R. et al. Hexylaminolevulinate photodynamic diagnosis for multifocal recurrent non-muscleinvasive bladder cancer. J. Endourol. 23, 983-988 (2009).
5. Stenzl, A. S. et al. Hexvix fluorescence cystoscopy improves detection and resection of papillary bladder cancer and reduces early recurrence: a multicentre prospective randomized study). Eur. Urol. Suppl. 8, 373 (2009).
6. Thomas, K. & O'Brien, T. S. Blue sky thinking about blue light cystoscopy. BJU Int. 104, 887-890 (2009).